Filing Impact
Filing Sentiment
Form Type
8-K
The company furnished a press release announcing financial results for the quarter ended September 30, 2025, attached as Exhibit 99.1.
See the press release included as Exhibit 99.1 to the 8-K.
No. The Item 2.02 and Exhibit 99.1 information is furnished, not filed, and not subject to Section 18 liabilities.
It covers the fiscal quarter ended September 30, 2025.
The company reported the event on November 13, 2025.
Alumis trades on the Nasdaq Global Select Market under the symbol ALMS.
Alumis Inc
Nov 25, 2025
[Form 4] ALUMIS INC. Insider Trading Activity
Nov 25, 2025
[Form 4] ALUMIS INC. Insider Trading Activity
Nov 25, 2025
[Form 4] ALUMIS INC. Insider Trading Activity
Nov 24, 2025
[Form 4] ALUMIS INC. Insider Trading Activity
Nov 19, 2025
[Form 4] ALUMIS INC. Insider Trading Activity
2.63B
62.82M
0.83%
81.07%
1.96%
Biotechnology
Pharmaceutical Preparations
United States
SOUTH SAN FRANCISCO